<?xml version="1.0" encoding="UTF-8"?>
<supplementary-material content-type="local-data" id="bjh15394-sup-0001">
 <caption>
  <p>
   <bold>Data S1.</bold> Supplementary methods.
  </p>
  <p>
   <bold>Table SI.</bold> Eligibility criteria.
  </p>
  <p>
   <bold>Table SII.</bold> Definitions of dose‐limiting toxicities.
  </p>
  <p>
   <bold>Table SIII.</bold> Treatment‐emergent AEs* reported at any grade in ≥25% of the total population and/or at grade 3 in ≥5% of the total population.
  </p>
 </caption>
 <media xlink:href="BJH-182-231-s001.docx" xmlns:xlink="http://www.w3.org/1999/xlink">
  <caption>
   <p>Click here for additional data file.</p>
  </caption>
 </media>
</supplementary-material>
